Trials / Completed
CompletedNCT02338544
Application of Epiduo(R) PUMP in Daily Practice in Patients With Inflammatory Acne
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,388 (actual)
- Sponsor
- Galderma Laboratorium GmbH · Industry
- Sex
- All
- Age
- 9 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this observational trial is to assess application and convenience of Epiduo® PUMP under daily clinical practice conditions in patients with moderate to severe inflammatory acne.
Detailed description
The objective of this observational trial is to assess application and convenience of Epiduo® PUMP under daily clinical practice conditions in patients with moderate to severe inflammatory acne using this drug in topical monotherapy or in combination with other drugs. In addition, efficacy of Epiduo® and incidence of adverse events will be assessed under marketed conditions. Also, patients' body beliefs will be recorded using the dysmorphic concern questionnaire. The observational study is designed as a multicentre study, covering all parts of Germany. Participating investigators are dermatologists with an adequate patient pool of acne patients. The observation time per patient will up to 3 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 0.1% Adapalene / 2.5% Benzoyl peroxide | Epiduo® gel containing 0.1% adapalene + 2.5% benzoyl peroxide dispensed from a pump. |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2015-09-01
- Completion
- 2015-09-01
- First posted
- 2015-01-14
- Last updated
- 2016-02-17
Source: ClinicalTrials.gov record NCT02338544. Inclusion in this directory is not an endorsement.